A detailed history of Advisors Management Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisors Management Group Inc holds 1,242 shares of ABBV stock, worth $207,724. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,242
Holding current value
$207,724
% of portfolio
0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $198,496 - $226,168
1,242 New
1,242 $226,000
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $1,659 - $1,990
12 Added 0.66%
1,843 $298,000
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $25,231 - $28,938
188 Added 11.44%
1,831 $246,000
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $6,743 - $8,573
49 Added 3.07%
1,643 $252,000
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $395 - $491
3 Added 0.19%
1,594 $258,000
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $170,921 - $216,264
1,591 New
1,591 $215,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Advisors Management Group Inc Portfolio

Follow Advisors Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Advisors Management Group Inc with notifications on news.